Pharmacogenetics and individualizing drug treatment during pregnancy.
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.Racial/ethnic disparities in magnesium sulfate neuroprotection: a subgroup analysis of a multicenter randomized controlled trial.Translational systems pharmacology studies in pregnant women.Value of Genetics-informed Drug Dosing Guidance in Pregnant Women: A Needs Assessment with Obstetric Healthcare Providers at Johns Hopkins.
P2860
Pharmacogenetics and individualizing drug treatment during pregnancy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacogenetics and individualizing drug treatment during pregnancy.
@ast
Pharmacogenetics and individualizing drug treatment during pregnancy.
@en
type
label
Pharmacogenetics and individualizing drug treatment during pregnancy.
@ast
Pharmacogenetics and individualizing drug treatment during pregnancy.
@en
prefLabel
Pharmacogenetics and individualizing drug treatment during pregnancy.
@ast
Pharmacogenetics and individualizing drug treatment during pregnancy.
@en
P2860
P356
P1433
P1476
Pharmacogenetics and individualizing drug treatment during pregnancy.
@en
P2093
David M Haas
P2860
P356
10.2217/PGS.13.228
P407
P577
2014-01-01T00:00:00Z